Strain Data Sheet

RBRC05651

Strain Information

Image
BRC No.RBRC05651
TypeTargeted MutationCartagena
SpeciesMus musculus
Strain nameB6;129-Sox9<tm1Haak>
Former Common nameSox9-EGFP KI, Sox9-EGFP knock-in, B6-Sox9/GFP KI
H-2 Haplotype
ES Cell line
Background strain
Appearance
Strain developmentDeveloped by Haruhiko Akiyama, The University of Texas MD Anderson Cancer Center. A loxP-flanked PGK-neo-bpA was removed by cre-mediated recombination. C57BL/6 and 129 mixed background.
Strain descriptionSox9-EGFP knock-in mice. An IRES-EGFP-pA cassette was inserted into the 3’ untranslated region in exon 3 of Sox9 gene via homologous recombination.
Colony maintenanceHomozygote x Homozygote [or Crossing to C57BL/6NCrlCrlj]
References
Morphometric analysis of testis cord formation in Sox9-EGFP mice.
Nel-Themaat L, Vadakkan T J, Wang Y, Dickinson M E, Akiyama H, Behringer R R
Dev. Dyn., 238, 1100-1110 (2009). 19384968

Health Report

Examination Date / Room / Rack2024/06/10Room:3-3Rack:C
2024/03/11Room:3-3Rack:C
2023/12/11Room:3-3Rack:C
2023/09/11Room:3-3Rack:C

Gene

Gene SymbolGene NameChr.Allele SymbolAllele NameCommon NamesPromoterDiseases Related to This Gene
EGFPEnhanced Green Fluorescent Protein (Aequorea victoria)11EGFP
  • campomelic dysplasia(DisGeNET, MedGEN)
  • IRESinternal ribosomal entry site (EMCV)11
  • campomelic dysplasia(DisGeNET, MedGEN)
  • Sox9SRY (sex determining region Y)-box 911Sox9targeted mutation 1, Haruhiko Akiyama
  • campomelic dysplasia(DisGeNET, MedGEN)
  • loxPphage P1 loxP11loxP
  • campomelic dysplasia(DisGeNET, MedGEN)
  • Phenotype

    Annotation by Mammalian phenotyhpe ontology
  • no abnormal phenotype detected(MP:0002169)
  • Detailed phenotype data

    Ordering Information

    Donor DNAEMCV internal ribosomal entry site (ires), jellyfish EGFP cDNA, phage P1 loxP site, bovine polyA signal, mouse Sox9 genomic DNA[update: Dec. 12, 2013]
    Research applicationCre/loxP system
    Developmental Biology Research
    Fluorescent Proteins/lacZ System
    Specific Term and ConditionsIn publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Dev. Dyn., 238, 1100-1110 (2009). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR and Dr. Haruhiko Akiyama, Kyoto University, is requested. Depositor retains ownership of the Biological Resource, including any Biological Resource contained in any modification. Any Biological Resource delivered pursuant to the Agreement is understood to be experimental in nature and may have hazardous properties. The DEPOSITOR MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE BIOLOGICAL RESOURCE WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS. In no event shall Depositor be liable for any use by recipient of the Biological Resource for any loss, claim, damage or liability, of whatsoever kind of nature, which may arise from or in connection with the use, handling or storage of the Biological Resource. Except where limited by Federal law, or by the constitution and laws of the state governing the recipient, the recipient agrees to hold harmless Depositor and The University of Texas System and their Regents, officers, agents and employees, from any liability, loss or damage they may suffer as a result of claims, demands, costs or judgments against them arising out of recipient’s use of the Material and the use by recipient of the results obtained from the Research. The Biological Resource and modifications containing the Biological Resource may only be transferred to non-profit institutions for academic research purposes.
    DepositorBenoit de Crombrugghe (The University of Texas M. D. Anderson Cancer Center)
    Strain Statusan icon for Frozen embryosFrozen embryos
    an icon for Frozen spermFrozen sperm
    Strain AvailabilityRecovered litters from cryopreserved embryos (2 to 4 months)
    Cryopreserved sperm (within 1 month)
    Cryopreserved embryos (within 1 month)
    Additional Info.Necessary documents for ordering:
    1. Order form (Japanese / English)
    2. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
    3. Acceptance of responsibility for living modified organism (Japanese / English)

    Genotyping protocol -PCR-

    BRC mice in Publications

    No Data